Search

Your search keyword '"Schaefer, Franz"' showing total 174 results
Start Over Author "Schaefer, Franz" Journal nephrology dialysis transplantation
174 results on '"Schaefer, Franz"'

1. Trends and socioeconomic inequality of the burden of congenital abnormalities of the kidney and urinary tract among children and adolescents

Author

He, Guohua, primary, Liu, Yunfei, additional, Bagga, Arvind, additional, Onubogu, Chinyere Ukamaka, additional, Schaefer, Franz, additional, Zou, Zhiyong, additional, Smoyer, William E, additional, Xiao, Nianzhou, additional, Lin, Tianxin, additional, Lanewala, Ali Asghar, additional, Kang, Hee Gyung, additional, Waheed, Muhammad Zeeshan, additional, Park, Seungkyo, additional, Jiang, Xiaoyun, additional, Song, Yi, additional, and Ding, Jie, additional

Published
2024
Full Text
View/download PDF

2. #1196 C3G and ic-MPGN across the life span: findings from the European Rare Kidney Disease Registry

Author

Schaefer, Franz, primary, Hofstetter, Jonas, additional, Ruiz, Enrique Morales, additional, Antonucci, Luca, additional, Conlon, Peter J, additional, Francesca, Becherucci, additional, Servais, Aude, additional, Kanzelmeyer, Nele, additional, Beltran, Victor Perez, additional, Imeraj, Amantia, additional, Mastrangelo, Antonio, additional, and Roccatello, Dario, additional

Published
2024
Full Text
View/download PDF

4. #2278 EUROCYS, a European cystinuria registry

Author

Servais, Aude, primary, Capolongo, Giovanna, additional, Tostivint, Isabelle, additional, Lemoine, Sandrine, additional, Ferraro, Pietro Manuel, additional, Decramer, Stephane, additional, Ruggenent, Piero, additional, Capelli, Irene, additional, Engberink, Rik Olde, additional, Schaefer, Franz, additional, Knebelmann, Bertrand, additional, and Courbebaisse, Marie, additional

Published
2024
Full Text
View/download PDF

8. Averting the legacy of kidney disease: focus on childhood

Author

Ingelfinger, Julie R, Kalantar-Zadeh, Kamyar, and Schaefer, Franz

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, World Kidney Day Steering Committee, Urology & Nephrology, Clinical sciences
Published
2016

11. The association of donor and recipient age with graft survival in paediatric renal transplant recipients in a European Society for Paediatric Nephrology/European Renal Association–European Dialysis and Transplantation Association Registry study

Author

Chesnaye, Nicholas C, van Stralen, Karlijn J, Bonthuis, Marjolein, Groothoff, Jaap W, Harambat, Jérôme, Schaefer, Franz, Canpolat, Nur, Garnier, Arnaud, Heaf, James, de Jong, Huib, Schwartz Sørensen, Søren, Tönshoff, Burkhard, and Jager, Kitty J

Published
2017
Full Text
View/download PDF

12. Definition, diagnosis and clinical management of non-obstructive kidney dysplasia: a consensus statement by the ERKNet Working Group on Kidney Malformations

Author

Kohl, Stefan, primary, Avni, Fred E, additional, Boor, Peter, additional, Capone, Valentina, additional, Clapp, William L, additional, De Palma, Diego, additional, Harris, Tess, additional, Heidet, Laurence, additional, Hilger, Alina C, additional, Liapis, Helen, additional, Lilien, Marc, additional, Manzoni, Gianantonio, additional, Montini, Giovanni, additional, Negrisolo, Susanna, additional, Pierrat, Marie-Jeanne, additional, Raes, Ann, additional, Reutter, Heiko, additional, Schreuder, Michiel F, additional, Weber, Stefanie, additional, Winyard, Paul J D, additional, Woolf, Adrian S, additional, Schaefer, Franz, additional, and Liebau, Max C, additional

Published
2022
Full Text
View/download PDF

13. MO1041: C.E.R.A. (Continuous Erythropoietin Receptor Activator—Methoxy Polyethylene Glycol Epoetin Beta) In Paediatric Dialysis Patients with Anaemia of Chronic Kidney Disease: Real-World Evidence from the IPDN and IPHN Registries

Author

Schaefer, Franz, primary, Benner, Laura, additional, Sander, Anja, additional, Rutten-Jacobs, Loes, additional, Hui Kim, Yap, additional, Vondrak, Karel, additional, Coccia, Paula A, additional, Cano, Francisco, additional, Meyer Reigner, Sylvie, additional, and Studer, Milena, additional

Published
2022
Full Text
View/download PDF

14. Treatment and long-term outcome in primary distal renal tubular acidosis

Author

Lopez-Garcia, Sergio Camilo, Emma, Francesco, Walsh, Stephen B, Fila, Marc, Hooman, Nakysa, Zaniew, Marcin, Bertholet-Thomas, Aurelia, Colussi, Giacomo, Burgmaier, Kathrin, Levtchenko, Elena, Sharma, Jyoti, Singhal, Jyoti, Soliman, Neveen A, Ariceta, Gema, Basu, Biswanath, Murer, Luisa, Tasic, Velibor, Tsygin, Alexey, Decramer, Stephane, Gil-Pena, Helena, Koster-Kamphuis, Linda, La Scola, Claudio, Gellermann, Jutta, Konrad, Martin, Lilien, Marc, Francisco, Telma, Tramma, Despoina, Trnka, Peter, Yuksel, Selcuk, Caruso, Maria Rosa, Chromek, Milan, Ekinci, Zelal, Gambaro, Giovanni, Kari, Jameela A, Koenig, Jens, Taroni, Francesca, Thumfart, Julia, Trepiccione, Francesco, Winding, Louise, Wuehl, Elke, Agbas, Ayse, Belkevich, Anna, Vargas-Poussou, Rosa, Blanchard, Anne, Conti, Giovanni, Boyer, Olivia, Dursun, Ismail, Pinarbasi, Ayse Seda, Melek, Engin, Miglinas, Marius, Novo, Robert, Mallett, Andrew, Milosevic, Danko, Szczepanska, Maria, Wente, Sarah, Cheong, Hae Il, Sinha, Rajiv, Gucev, Zoran, Dufek, Stephanie, Iancu, Daniela, Kleta, Robert, Schaefer, Franz, Bockenhauer, Detlef, Peco-Antic, Amira, Kaur, Amrit, Paglialunga, Antonino, Servais, Aude, Lutovac, Branko, Hoorn, Ewout J, Shasha-Lavsky, Hadas, Harambat, Jerome, Godron-Dubrasquet, Astrid, Buder, Kathrin, Allard, Lise, Patzer, Ludwig, Shumikhina, Marina, Hansen, Matthias, Printza, Nikoleta, Kucuk, Nuran, Beringer, Ortraud, Bhimma, Rajendra, Cerkauskiene, Rimante, Klinikos, Santaros, Neuhaus, Thomas J, Stavileci, Valbona, Ulinski, Tim, Dincel, Nida Temizkan, Mohebbi, Nilufar, Çukurova Üniversitesi, Lopez-Garcia, Sergio Camilo, Emma, Francesco, Walsh, Stephen B, Fila, Marc, Hooman, Nakysa, Zaniew, Marcin, Bertholet-Thomas, Aurélia, Colussi, Giacomo, Burgmaier, Kathrin, Levtchenko, Elena, Sharma, Jyoti, Singhal, Jyoti, Soliman, Neveen A, Ariceta, Gema, Basu, Biswanath, Murer, Luisa, Tasic, Velibor, Tsygin, Alexey, Decramer, Stéphane, Gil-Peña, Helena, Koster-Kamphuis, Linda, La Scola, Claudio, Gellermann, Jutta, Konrad, Martin, Lilien, Marc, Francisco, Telma, Tramma, Despoina, Trnka, Peter, Yüksel, Selçuk, Caruso, Maria Rosa, Chromek, Milan, Ekinci, Zelal, Gambaro, Giovanni, Kari, Jameela A, König, Jen, Taroni, Francesca, Thumfart, Julia, Trepiccione, Francesco, Winding, Louise, Wühl, Elke, Ağbaş, Ayşe, Belkevich, Anna, Vargas-Poussou, Rosa, Blanchard, Anne, Conti, Giovanni, Boyer, Olivia, Dursun, Ismail, Pınarbaşı, Ayşe Seda, Melek, Engin, Miglinas, Mariu, Novo, Robert, Mallett, Andrew, Milosevic, Danko, Szczepanska, Maria, Wente, Sarah, Cheong, Hae Il, Sinha, Rajiv, Gucev, Zoran, Dufek, Stephanie, Iancu, Daniela, Kleta, Robert, Schaefer, Franz, Bockenhauer, Detlef, and Internal Medicine

Subjects
Male, glomerulus filtration rate, ATP6V1B1 protein, human, DNA Mutational Analysis, kidney calcification, distal renal tubular acidosis, Sensorineural, nephrocalcinosi, ATP6V1B1 gene, Renal tubular acidosis, 0302 clinical medicine, newborn, Chronic kidney disease, middle aged, Medicine, genetics, Young adult, Child, adult, cohort analysis, perception deafness, Sensorineural hearing loss, aged, Nephrocalcinosis, priority journal, Nephrology, Child, Preschool, Cohort, Acidosis, mutational analysis, Vacuolar Proton-Translocating ATPases, medicine.medical_specialty, Hearing Loss, Sensorineural, rare disease, Renal function, bicarbonate, complication, Article, 03 medical and health sciences, nephrocalcinosis, Humans, human, gross national product, Hearing Loss, Aged, Infant, economic aspect, Distal renal tubular acidosis, medicine.disease, major clinical study, proton transporting adenosine triphosphate synthase, Mutation, nephrolithiasis, estimated glomerular filtration rate, chronic kidney disease, SLC4A1 gene, 030232 urology & nephrology, Deafness, 030204 cardiovascular system & hematology, preschool child, sensorineural hearing loss, nephrolithiasi, Cohort Studies, distal renal tubular acidosi, Interquartile range, kidney tubule acidosis, gene mutation, kidney function, Acidosis, Renal Tubular, chronic kidney failure, Middle Aged, urine, female, genetic association study, medical care, body height, young adult, Female, Renal Tubular, Glomerular Filtration Rate, onset age, Adult, Adolescent, prevalence, Nephrolithiasis, Young Adult, Rare Diseases, primary distal renal tubular acidosis, blood, Internal medicine, follow up, gene, Preschool, outcome assessment, Genetic Association Studies, Transplantation, calcium, business.industry, Infant, Newborn, hearing impairment, Newborn, Bicarbonates, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], Calcium, metabolic regulation, business, Kidney disease
Abstract

PubMedID: 30773598 Background. Primary distal renal tubular acidosis (dRTA) is a rare disorder, and we aimed to gather data on treatment and long-Termoutcome. Methods. We contacted paediatric and adult nephrologists through European professional organizations. Responding clinicians entered demographic, biochemical, genetic and clinical data in an online form. Results. Adequate data were collected on 340 patients (29 countries, female 52%). Mutation testing had been performed on 206 patients (61%); pathogenic mutations were identified in 170 patients (83%). The median (range) presentation age was 0.5 (0-54) years and age at last follow-up was 11.0 (0-70.0) years. Adult height was slightly below average with a mean (SD score) of -0.57 (61.16). There was an increased prevalence of chronic kidney disease (CKD) Stage -2 in children (35%) and adults (82%). Nephrocalcinosis was reported in 88%. Nephrolithiasis was more common with SLC4A1 mutations (42% versus 21%). Thirty-six percent had hearing loss, particularly in ATP6V1B1 (88%). The median (interquartile range) prescribed dose of alkali (mEq/kg/day) was 1.9 (1.2-3.3). Adequate metabolic control (normal plasma bicarbonate and normocalciuria) was achieved in 158 patients (51%), more commonly in countries with higher gross domestic product (67% versus 23%), and was associated with higher height and estimated glomerular filtration rate. Conclusion. Long-Term follow-up from this large dRTA cohort shows an overall favourable outcome with normal adult height for most and no patient with CKD Stage 5. However, 82% of adult patients have CKD Stages 2-4. Importance of adequate metabolic control was highlighted by better growth and renal function but was achieved in only half of patients. © The Author(s) 2018. Erciyes Üniversitesi Iran University of Medical Sciences Università degli Studi di Padova Chung Hua University American Ornithologists' Union University of Queensland 7Centre University College London Aristotle University of Thessaloniki Lunds Universitet Cairo University National Rosacea Society Heart of England NHS Foundation Trust Centre hospitalier universitaire Sainte-Justine Erasmus Universiteit Rotterdam Aristotle University of Thessaloniki 1Department of Paediatric Nephrology, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK, 2Centre for Nephrology, University College London, London, UK, 3Division of Nephrology, Bambino Gesù Children’s Hospital—IRCCS, Rome, Italy, 4Pediatric Nephrology—CHU Arnaud de Villeneuve, Montpellier University Hospital, Montpellier, France, 5Ali-Asghar Clinical Research Development Center, Iran University of Medical Sciences, Tehran, Iran, 6Department of Pediatrics, University of Zielona Góra, Zielona Góra, Poland, 7Centre de référence Maladies rénales rares, Bron, France, 8ASST Niguarda, Milan, Italy, 9Department of Pediatrics, University Hospital of Cologne, Cologne, Germany, 10University Hospital Leuven, Leuven, Belgium, 11King Edward Memorial Hospital, Pune, India, 12Department of Pediatrics, Center of Pediatric Nephrology & Transplantation, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt, 13Hospital Universitario Vall d’Hebron, Barcelona, Spain, 14Division of Pediatric Nephrology, NRS Medical College, Kolkata, India, 15Pediatric Nephrology, Dialysis and Transplant Unit, Azienda Ospedaliera & University of Padova, Padova, Italy, 16University Children’s Hospital, Medical School, Skopje, Macedonia, 17National Medical and Research Centre for Children’s Health, Moscow, Russia, 18Centre Hospitalier Universitaire de Toulouse, Service de Nephrologie Pediatrique, Hopital des Enfants, Centre De Reference des Maladies Rénales Rares du Sud Ouest, Toulouse, France, 19Hospital Universitario Central de Asturias, Oviedo, Spain, 20Radboud University Medical Centre, Nijmegen, The Netherlands, 21Nephrology and Dialysis Unit, Department of Woman, Child and Urological Diseases, Azienda Ospedaliero—Universitaria Sant’Orsola-Malpighi, Bologna, Italy, 22Charité Universitätsmedizin Berlin, Berlin, Germany, 23University Children’s Hospital, Münster, Germany, 24Wilhelmina Children’s Hospital, University Medical Center, Utrecht, The Netherlands, 25Centro Hospitalar de Lisboa Central, Lisbon, Portugal, 26Fourth Pediatric Department, Aristotle University, Thessaloniki, Greece, 27Lady Cilento Children’s Hospital, Brisbane, Australia, 28School of Medicine, the University of Queensland, Brisbane, Australia, 29Department of Pediatric Nephrology, Pamukkale University School of Medicine, Denizli, Turkey, 30Nephrology Unit Azienda Ospedaliera, Papa Giovani XXIII, Bergamo, Italy, 31Karolinska Institutet, Lund University,Sweden,GroupFlorenceNightingaleHospitals,Ist32· anbul, Turkey,Fondazione Policlinico A. Gemelli, Universita` Cattolica del33 Sacro Cuore, Rome, Italy, 34Pediatric Nephrology Center of Excellence and Pediatric Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia, 35Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Milan, Italy, 36Department of Translational Medical Sciences, University of Campania “L. Vanvitelli”, Naples, Italy, 37Pediatric Department, Lillebaelt Hospital Kolding, Kolding, Denmark, 38Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University Hospital of Heidelberg, Heidelberg, Germany, 39Haseki Education and Research Hospital, Istanbul, Turkey, 40Belarusian State Medical University, Minsk, Belarus, 41Department of Genetics, Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France, 42Pediatric Nephrology Unit, AOU Policlinic G Martino, Messina, Italy, 43Necker Hospital, Paris, France, 44Faculty of Medicine, Department of Pediatric Nephrology, Erciyes University, Kayseri, Turkey, 45Cukurova University, Adana, Turkey, 46Nephrology Centre, Santaros Klinikos, Vilnius University, Vilnius, Lithuania, 47University Hospital of Lille, France, 48Department of Renal Medicine, Royal Brisbane and Women’s Hospital, Brisbane, Australia, 49University Hospital Centre Zagreb, Zagreb, Croatia, 50Department of Pediatrics, SMDZ in Zabrze, SUM in Katowice, Poland, 51Department of Pediatric Nephrology, Hannover Medical School, Hannover, Germany, The European dRTA Consortium consists of the authors, as well as: Amira Peco-Antic(Department of Nephrology, University Children’s Hospital, Belgrade, Serbia), Amrit Kaur (Department of Paediatric Nephrology, Royal Manchester Children’s Hospital, Manchester, UK), Antonino Paglialunga (ASP de Ragusa, Modica, Italy), Aude Servais (Department of Nephrology, Centre Hospitalier Universitaire Necker, APHP, Paris, France), Branko Lutovac (Clinical Centre of Montenegro, Institute for Children’s Disease, Podgorica, Montenegro), Ewout J. Hoorn (Erasmus Medical Center, Rotterdam, The Netherlands), Hadas Shasha-Lavsky (Galilee Medical Center, Nahariya, Israel), Jerome Harambat (Pediatric Nephrology Unit, Bordeaux University Hospital, Bordeaux, France), Astrid Godron-Dubrasquet (Pediatric Nephrology Unit, Bordeaux University Hospital, Bordeaux, France), Kathrin Buder (Pediatric Department, University Hospital, Carl Gustav Carus Dresden, Dresden, Germany), Lise Allard (Department of Pediatrics, Angers University Hospital, Angers, France), Ludwig Patzer (Children’s Hospital St Elisabeth and St Barbara, Halle, Germany), Marina Shumikhina (Filatov Children’s Clinical Hospital No. 13, Moscow, Russia), Matthias Hansen (KfH Centre of Paediatric Nephrology, Clementine Children’s Hospital, Frankfurt, Germany), Nikoleta Printza (First Pediatric Department, Aristotle University, Thessaloniki, Greece), Nuran Küc¸ük (Kartal Dr. Lütfi Kırdar Training and Research Hospital, İstanbul, Turkey), Ortraud Beringer (University Children’s Hospital, Ulm, Germany), Rajendra Bhimma (Inkosi Albert Luthuli, Central Hospital, Durban, South Africa), Rimante Cerkauskiene (Faculty of Medicine, Children’s Hospital, Vilnius University, Vilnius, Lithuania; Santaros Klinikos, Vilnius University Hospital, Vilnius, Lithuania), Thomas J. Neuhaus (Children’s Hospital of Lucerne, Cantonal Hospital of Lucerne, Lucerne, Switzerland), Valbona Stavileci (Pediatric Clinic, Prishtina, Kosovo), Tim Ulinski (Pediatric Nephrology Department, Armand Trousseau University Hospital, APHP, Paris, France), Nida Temizkan Dincel (Health Sciences University, Izmir Dr Behcet Uz Children’s Hospital, İzmir, Turkey) and Nilufar Mohebbi (Division of Nephrology, University Hospital Zurich, Zurich, Switzerland)

Published
2019

15. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

Author

Müller, Roman-Ulrich, primary, Messchendorp, A Lianne, additional, Birn, Henrik, additional, Capasso, Giovambattista, additional, Cornec-Le Gall, Emilie, additional, Devuyst, Olivier, additional, van Eerde, Albertien, additional, Guirchoun, Patrick, additional, Harris, Tess, additional, Hoorn, Ewout J, additional, Knoers, Nine V A M, additional, Korst, Uwe, additional, Mekahli, Djalila, additional, Le Meur, Yannick, additional, Nijenhuis, Tom, additional, Ong, Albert C M, additional, Sayer, John A, additional, Schaefer, Franz, additional, Servais, Aude, additional, Tesar, Vladimir, additional, Torra, Roser, additional, Walsh, Stephen B, additional, and Gansevoort, Ron T, additional

Published
2021
Full Text
View/download PDF

16. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Author

Gansevoort, Ron T., Arici, Mustafa, Benzing, Thomas, Birn, Henrik, Capasso, Giovambattista, Covic, Adrian, Devuyst, Olivier, Drechsler, Christiane, Eckardt, Kai-Uwe, Emma, Francesco, Knebelmann, Bertrand, Le Meur, Yannick, Massy, Ziad A., Ong, Albert C.M., Ortiz, Alberto, Schaefer, Franz, Torra, Roser, Vanholder, Raymond, Więcek, Andrzej, Zoccali, Carmine, and Van Biesen, Wim

Published
2016
Full Text
View/download PDF

17. Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry

Author

Lofaro, Danilo, Jager, Kitty J., Abu-Hanna, Ameen, Groothoff, Jaap W., Arikoski, Pekka, Hoecker, Britta, Roussey-Kesler, Gwenaelle, Spasojević, Brankica, Verrina, Enrico, Schaefer, Franz, van Stralen, Karlijn J., Coppo, R., Haffner, D., Harambat, J., Stefanidis, C., Shitza, D., Kramar, R., Oberbauer, R., Baiko, S., Sukalo, A., van Hoeck, K., Collart, F., des Grottes, J.M., Pokrajac, D., Resić, H., Prnjavorac, B., Roussinov, D., Batinić, D., Lemac, M., Slavicek, J., Seeman, T., Vondrak, K., Heaf, J.G., Toots, U., Finne, P., Grönhagen-Riska, C., Couchoud, C., Lasalle, M., Sahpazova, E., Gersdorf, G., Barth, C., Scholz, C., Tönshoff, B., Ioannidis, G., Kapogiannis, A., Papachristou, F., Reusz, G., Túri, S., Szabó, L., Szabó, T., Reusz, G., Györke, Zs., Kis, E., Palsson, R., Edvardsson, V., Mencarelli, F., Paglialonga, F., Pecoraro, C., Picca, S., Roperto, R., Vidal, E., Verrina, E., Jankauskiene, A., Pundziene, B., Said-Conti, V., Gatcan, S., Berbeca, O., Zaikova, N., Pavićević, S., Leivestad, T., Bjerre, A., Zurowska, A., Zagozdzon, I., Mota, C., Almeida, M., Afonso, C., Mircescu, G., Garneata, L., Podgoreanu, E., Molchanova, E.A., Tomilina, N.A., Bikbov, B.T., Kostic, M., Peco-Antic, A., Puric, S., Kruscic, D., Spasojevic-Dimitrijeva, B., Milosecski-Lomic, G., Paripovic, D., Podracka, L., Kolvek, G., Buturovic-Ponikvar, J., Novljan, G., Battelino, N., Alonso Melgar, A., Schön, S., Prütz, K.G., Seeberger, A., Backmän, L., Evans, M., Kuenhi, C.E., Maurer, E., Laube, G., Simometi, G., Hoitsma, A., Hemke, A., Topaloglu, R., Duzova, A., Ivanov, D., and Sinha, M.

Published
2016
Full Text
View/download PDF

18. Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium

Author

Wuttke, Matthias, Wong, Craig S., Wühl, Elke, Epting, Daniel, Luo, Li, Hoppmann, Anselm, Doyon, Anke, Li, Yong, Sözeri, Betül, Thurn, Daniela, Helmstädter, Martin, Huber, Tobias B., Blydt-Hansen, Tom D., Kramer-Zucker, Albrecht, Mehls, Otto, Melk, Anette, Querfeld, Uwe, Furth, Susan L., Warady, Bradley A., Schaefer, Franz, and Köttgen, Anna

Published
2016
Full Text
View/download PDF

19. Acute paediatric kidney replacement therapies in Europe: demographic results from the EurAKId Registry

Author

Guzzo, Isabella, primary, de Galasso, Lara, additional, Bayazit, Aysun Karabay, additional, Yildizdas, Dincer, additional, Schmitt, Claus Peter, additional, Hayes, Wesley, additional, Shroff, Rukshana, additional, Jankauskiene, Augustina, additional, Virsilas, Ernestas, additional, Longo, Germana, additional, Vidal, Enrico, additional, Mir, Sevgi, additional, Bulut, Ipek Kaplan, additional, Tkaczyk, Marcin, additional, Mencarelli, Francesca, additional, Bertulli, Cristina, additional, Cvetkovic, Mrjana, additional, Kostic, Mirjana, additional, Paglialonga, Fabio, additional, Montini, Giovanni, additional, Yilmaz, Ebru, additional, Teixeira, Ana, additional, Atmis, Bahriye, additional, and Schaefer, Franz, additional

Published
2021
Full Text
View/download PDF

22. FC 133HEMODIAFILTRATION IS ASSOCIATED WITH REDUCED INFLAMMATION AND INCREASED BONE TURNOVER COMPARED TO CONVENTIONAL HEMODIALYSIS IN CHILDREN - THE HDF, HEART AND HEIGHT (3H) STUDY

Author

Fischer, Dagmar-Christiane, primary, Smith, Colette, additional, De Zan, Francesca, additional, Askiti, Varvara, additional, Bayazit, Aysun Karabay, additional, Canpolat, Nur, additional, Litwin, Mieczyslaw, additional, Paglialonga, Fabio, additional, Schaefer, Franz, additional, Schmitt, Claus, additional, and Shroff, Rukshana, additional

Published
2021
Full Text
View/download PDF

23. MO001THE EUROPEAN DRTA REGISTRY: AN INITIAL DATA ANALYSIS*

Author

Bockenhauer, Detlef, primary, Emma, Francesco, additional, Talhi, Amina, additional, Papizh, Svetlana, additional, Atmis, Bahriye, additional, Homan, Nakisa, additional, Aksu, Bagdagul, additional, Santos, Fernando, additional, Boyer, Olivia, additional, Fila, Marc, additional, Bayrakci, Umut Selda, additional, Ouda Eid, Loai Akram, additional, VanDyck, Maria, additional, Moguel, Carlos, additional, Yüksel, Selçuk, additional, Canpolat, Nur, additional, Schaefer, Franz, additional, Oh, Jun, additional, Liebau, Max, additional, Ariceta Iraola, Maria Gema, additional, Vargas-Poussou, Rosa, additional, Levtchenko, Elena, additional, Lopez-Garcia, Sergio Camilo, additional, Wlodkowski, Tanja, additional, and Topologlu, Rezan, additional

Published
2021
Full Text
View/download PDF

24. MO107CLINICAL CHARACTERISTICS OF A PATIENT POPULATION WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME AND MALIGNANT HYPERTENSION: THE GLOBAL AHUS REGISTRY ANALYSIS

Author

Halimi, Jean-Michel, primary, Al-Dakkak, Imad, additional, Anokhina, Katerina, additional, Ardissino, Gianluigi, additional, Licht, Christoph, additional, Lim, Wai, additional, Massart, Annick, additional, Schaefer, Franz, additional, Van de Walle, Johan, additional, and Rondeau, Eric, additional

Published
2021
Full Text
View/download PDF

25. FC 130RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3B TRIAL OF TOLVAPTAN IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): 1-YEAR DATA

Author

Mekahli, Djalila, primary, Guay-Woodford, Lisa, additional, Cadnaparphornchai, Melissa, additional, Greenbaum, Laurence A, additional, Litwin, Mieczysław, additional, Seeman, Tomas, additional, Dandurand, Ann, additional, Shi, Lily, additional, Sikes, Kimberley, additional, Shoaf, Susan, additional, and Schaefer, Franz, additional

Published
2021
Full Text
View/download PDF

26. FC 109GLUCOSE DERIVATIVE INDUCED VASCULOPATHY IN CHILDREN ON PERITONEAL DIALYSIS

Author

Bartosova, Maria, primary, Schaefer, Betti, additional, Zhang, Conghui, additional, Herzog, Rebecca, additional, Ridinger, David, additional, Damgov, Ivan, additional, Lévai, Eszter, additional, Marinovic, Iva, additional, Eckert, Christoph, additional, Romero, Philipp, additional, Sallay, Peter, additional, Ujszaszi, Akos, additional, Unterwurzacher, Markus, additional, Wagner, Anja, additional, Hildenbrand, Georg, additional, Warady, Bradley, additional, Schaefer, Franz, additional, Zarogiannis, Sotirios G, additional, Kratochwill, Klaus, additional, and Schmitt, Claus, additional

Published
2021
Full Text
View/download PDF

30. update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

Author

Müller, Roman-Ulrich, Messchendorp, A Lianne, Birn, Henrik, Capasso, Giovambattista, Gall, Emilie Cornec-Le, Devuyst, Olivier, Eerde, Albertien van, Guirchoun, Patrick, Harris, Tess, Hoorn, Ewout J, Knoers, Nine V A M, Korst, Uwe, Mekahli, Djalila, Meur, Yannick Le, Nijenhuis, Tom, Ong, Albert C M, Sayer, John A, Schaefer, Franz, Servais, Aude, and Tesar, Vladimir

Subjects
POLYCYSTIC kidney disease, KIDNEY diseases, CHRONIC kidney failure, PATIENT selection, CLINICAL trials, DIABETES insipidus
Abstract

Approval of the vasopressin V2 receptor antagonist tolvaptan—based on the landmark TEMPO 3:4 trial—marked a transformation in the management of autosomal dominant polycystic kidney disease (ADPKD). This development has advanced patient care in ADPKD from general measures to prevent progression of chronic kidney disease to targeting disease-specific mechanisms. However, considering the long-term nature of this treatment, as well as potential side effects, evidence-based approaches to initiate treatment only in patients with rapidly progressing disease are crucial. In 2016, the position statement issued by the European Renal Association (ERA) was the first society-based recommendation on the use of tolvaptan and has served as a widely used decision-making tool for nephrologists. Since then, considerable practical experience regarding the use of tolvaptan in ADPKD has accumulated. More importantly, additional data from REPRISE, a second randomized clinical trial (RCT) examining the use of tolvaptan in later-stage disease, have added important evidence to the field, as have post hoc studies of these RCTs. To incorporate this new knowledge, we provide an updated algorithm to guide patient selection for treatment with tolvaptan and add practical advice for its use. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

31. Underweight, overweight and obesity in paediatric dialysis and renal transplant patients

Author

Bonthuis, Marjolein, van Stralen, Karlijn J., Verrina, Enrico, Groothoff, Jaap W., Alonso Melgar, Ángel, Edefonti, Alberto, Fischbach, Michel, Mendes, Patricia, Molchanova, Elena A., Paripović, Dušan, Peco-Antic, Amira, Printza, Nikoleta, Rees, Lesley, Rubik, Jacek, Stefanidis, Constantinos J., Sinha, Manish D., Zagożdżon, Ilona, Jager, Kitty J., and Schaefer, Franz

Published
2013
Full Text
View/download PDF

35. Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice.

Author

Knoers, Nine, Antignac, Corinne, Bergmann, Carsten, Dahan, Karin, Giglio, Sabrina, Heidet, Laurence, Lipska-Ziętkiewicz, Beata S, Noris, Marina, Remuzzi, Giuseppe, Vargas-Poussou, Rosa, and Schaefer, Franz

Subjects
CHRONIC kidney failure, GENETIC testing, KIDNEY disease diagnosis, GENETIC disorder diagnosis, GENETIC counseling
Abstract

The overall diagnostic yield of massively parallel sequencing–based tests in patients with chronic kidney disease (CKD) is 30% for paediatric cases and 6–30% for adult cases. These figures should encourage nephrologists to frequently use genetic testing as a diagnostic means for their patients. However, in reality, several barriers appear to hinder the implementation of massively parallel sequencing–based diagnostics in routine clinical practice. In this article we aim to support the nephrologist to overcome these barriers. After a detailed discussion of the general items that are important to genetic testing in nephrology, namely genetic testing modalities and their indications, clinical information needed for high-quality interpretation of genetic tests, the clinical benefit of genetic testing and genetic counselling, we describe each of these items more specifically for the different groups of genetic kidney diseases and for CKD of unknown origin. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

44. Patient- and parent proxy-reported outcome measures for life participation in children with chronic kidney disease: a systematic review

Author

Kerklaan, Jasmijn, primary, Hannan, Elyssa, additional, Baumgart, Amanda, additional, Manera, Karine E, additional, Ju, Angela, additional, McCulloch, Mignon, additional, Admani, Bashir, additional, Dominello, Amanda, additional, Esezobor, Christopher, additional, Foster, Bethany, additional, Hamilton, Alexander, additional, Jankauskiene, Augustina, additional, Johnson, Rebecca J, additional, Liu, Isaac, additional, Marks, Stephen D, additional, Neu, Alicia, additional, Schaefer, Franz, additional, Sutton, Shanna, additional, Wolfenden, Sebastian, additional, Craig, Jonathan C, additional, Groothoff, Jaap, additional, Howell, Martin, additional, and Tong, Allison, additional

Published
2020
Full Text
View/download PDF

45. MO078HEMODIAFILTRATION MAINTAINS A SUSTAINED IMPROVEMENT IN BP COMPARED TO CONVENTIONAL HEMODIALYSIS IN CHILDREN - THE HDF, HEART AND HEIGHT (3H) STUDY

Author

De Zan, Francesca, primary, Bayazit, Aysun Karabay, primary, Azukaitis, Karolis, primary, Canpolat, Nur, primary, Bakkaloglu, Sevcan, primary, Krid, Saoussen, primary, Litwin, Mieczysław, primary, Paglialonga, Fabio, primary, Samaille, Charlotte, primary, Shenoy, Mohan, primary, Sinha, Manish, primary, Spasojevic, Brankica, primary, Schmitt, Claus, primary, Schaefer, Franz, primary, Vidal, Enrico, primary, and Shroff, Rukshana, primary

Published
2020
Full Text
View/download PDF

46. MO026TREATMENT WITH ACTIVE VITAMIN D DOES NOT IMPROVE LEFT VENTRICULAR HYPERTROPHY BUT FURTHER INCREASES FGF23 AND ACCELERATES CKD PROGRESSION IN CHILDREN

Author

Leifheit-Nestler, Maren, primary, Schoen, Anne, primary, Deppe, Jennifer, primary, Karabay Bayazit, Aysun, primary, Obrycki, Łukasz, primary, Canpolat, Nur, primary, Kaplan Bulut, Ipek, primary, Azukaitis, Karolis, primary, Stangl, Gabriele, primary, Behnisch, Rouven, primary, Shroff, Rukshana, primary, Bacchetta, Justine, primary, Querfeld, Uwe, primary, Schaefer, Franz, primary, and Haffner, Dieter, primary

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results